Bill

Bill > S0860


FL S0860

FL S0860
Compounded Drugs


summary

Introduced
12/10/2025
In Committee
12/16/2025
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

An act relating to compounded drugs; creating s. 499.038, F.S.; defining the term “compounded medication”; prohibiting any person or entity from engaging in the sale, transfer, or distribution of compounded medications for weight loss unless they provide specified documentation to the Department of Business and Professional Regulation; providing administrative penalties; authorizing the department to adopt rules and conduct inspections as necessary to implement specified provisions; providing an effective date. WHEREAS, the Legislature finds that the safety and integrity of compounded medications are paramount for the health and well-being of the residents of this state, and WHEREAS, the Legislature recognizes that while the United States Food and Drug Administration (FDA) sets internationally recognized standards for drug approval and regulatory oversight, there have been increasing attempts by bad actors to circumvent these regulations, undermining public trust and patient safety, and WHEREAS, the Legislature further finds that foreign entities, including those from countries such as China, have exploited regulatory gaps to introduce inferior or contaminated active pharmaceutical ingredients into the supply chain for medications intended for compounding, and WHEREAS, recent cases, including those involving medications for weight loss, have demonstrated that high demand can lead to the proliferation of the use of illicit, substandard, and potentially harmful active pharmaceutical ingredients that jeopardize patient health and safety, and WHEREAS, while the FDA bears responsibility for enforcing federal laws to protect citizens from misbranded and adulterated pharmaceutical ingredients, its enforcement has proven insufficient to curtail the influx of these substances into this state, and despite FDA action to curb imports of active pharmaceutical ingredients for weight loss medications from entities that are not compliant with current good manufacturing practices, patients in our state remain at risk of receiving compounded medications containing such active pharmaceutical ingredients, and WHEREAS, the Legislature therefore finds it necessary for the state to take action to protect its residents by ensuring that all active pharmaceutical ingredients used in compounding are sourced from reputable, registered, and inspected establishments, and that only pharmaceutical-grade, safe, and unadulterated ingredients are used in medications for weight loss, NOW, THEREFORE,

AI Summary

This bill creates new regulations for compounded medications, specifically targeting weight loss drugs, by establishing strict documentation and quality control requirements for their sale and distribution. The bill defines a "compounded medication" as a customized drug prepared by a licensed pharmacist or physician by combining or altering existing drug ingredients when a commercially available medication cannot meet a patient's specific health need. Pharmacists and entities selling compounded weight loss medications must now provide comprehensive documentation to the Department of Business and Professional Regulation, including proving that active pharmaceutical ingredients are FDA-approved, pharmaceutical-grade, and accompanied by a valid certificate of analysis. The documentation must also confirm that the ingredients were manufactured in FDA-registered facilities that have been recently inspected and comply with good manufacturing practices. Violations of these requirements can result in significant penalties, including a $1,000 fine per dose of illegally compounded medication and potential revocation of professional licenses. The bill's underlying motivation is to protect patient safety by preventing the use of substandard or contaminated pharmaceutical ingredients, particularly those from foreign sources that might exploit regulatory gaps. The legislation empowers the department to adopt rules and conduct inspections to enforce these new requirements, with the ultimate goal of ensuring the integrity and safety of compounded medications.

Sponsors (1)

Last Action

Introduced (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...